Inventor

Mi Chen

Inventor
San Diego, CA, US

Overview

22→
Patents
2004–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes22%
C07CAcyclic or carbocyclic compounds12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
Y02ATechnologies for adaptation to climate change5%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
10,336,769Gonadotropin-releasing hormone receptor antagonists and methods relating thereto201910,040,759Substituted azetidinyl compounds as GlyT1 inhibitors20189,708,334'Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors'20179,624,200'Therapeutic piperazines'20179,422,310'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20168,952,161'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20158,927,546'Therapeutic piperazines'20158,507,536'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20138,481,738'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20138,263,588'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20128,119,819'Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators'20128,084,614'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'20118,080,665'Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors'20117,994,318'Coumarin derivatives useful as TNFα inhibitors'20117,872,142'Coumarin derivatives useful as TNFα inhibitors'20117,709,664'Coumarin derivatives useful as TNFα inhibitors'20107,524,969'Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators'20097,449,482'Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors'20087,385,063'Method for preparing imidazole derivatives'20087,279,477'Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators'20077,026,491'Coumarin derivatives useful as TNFα inhibitors'20066,730,796'Process for preparation of N-substituted 2-sulfanylimidazoles'2004

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2004–2012Patents assigned to CHUGAI PHARMACEUTICAL CO LTD (11)· patent assignee history
2004–2019Based in San Diego, CA, US· patent location history
2011–2015Patents assigned to CHEN MI (7)· patent assignee history
2011–2019Patents assigned to NEUROCRINE BIOSCIENCES INC (7)· patent assignee history
2011–2013Patents assigned to ASHWEEK NEIL (4)· patent assignee history
2011–2013Patents assigned to BEATON GRAHAM (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CHUGAI PHARMACEUTICAL CO LTD112004–2012
CHEN MIself72011–2015
NEUROCRINE BIOSCIENCES INC72011–2019
ASHWEEK NEIL42011–2013
BEATON GRAHAM42011–2013
Locations
LocationPatentsSpan
San Diego, California, US222004–2019